Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2018-02-06 Earnings Release
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
ALK offentliggør årsrapport for 2017
Earnings Release Classification · 92% confidence The document is a press release summarizing ALK-Abelló A/S’s full-year 2017 and Q4 financial results and providing forward guidance, along with an audio cast/investor conference invitation. It contains key highlights of revenue, EBITDA, and outlook, consistent with an initial earnings announcement rather than the full Annual Report. Therefore, it is classified as an Earnings Release. FY 2017
2018-02-06 Danish
ALK offentliggør årsrapport for 2017
Annual Report Classification · 100% confidence The document is the full 'Annual Report 2017' for ALK-Abelló A/S. It contains comprehensive financial statements, management's review, auditor's report, and detailed performance analysis for the full fiscal year. It is not an announcement of a report, but the report itself, containing over 80 pages of detailed financial and operational data. FY 2017
2018-02-06 English
Director's Dealing 2017
Director's Dealing Classification · 99% confidence The document is a formal notification issued by ALK-Abelló A/S, referencing the Market Abuse Regulation (MAR) Article 19. It details a transaction (subscription of new shares) executed by Lundbeckfond Invest A/S, which is closely associated with a person discharging managerial responsibilities (PDMR) at ALK. This type of filing specifically reports personal share transactions by directors or closely associated persons. This directly matches the definition for Director's Dealing (DIRS). The document structure, detailing the person, the reason for reporting, the issuer, and the transaction specifics (price, quantity, date), confirms this classification.
2017-12-11 Danish
Director's Dealing 2017
Director's Dealing Classification · 99% confidence The document explicitly reports on a transaction involving shares ('B-shares and associated securities') by a person closely associated with a person discharging managerial responsibilities (Lundbeckfond Invest A/S associated with a board member). This type of mandatory disclosure, often required under regulations like MAR (Market Abuse Regulation, mentioned in the text), concerns insider trading or executive/director dealings. This directly matches the definition for Director's Dealing (DIRS). It is not an earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS), as it pertains to a very specific insider transaction disclosure.
2017-12-11 English
Indberetning af transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer udført af personer med nær tilknytning til personer med ledelsesansvar
Director's Dealing Classification · 95% confidence The document is a regulatory notification filed under Market Abuse Regulation article 19, detailing a transaction by a person closely associated with a board member (subscription of new shares, price, volume, date). This is an insider transaction disclosure by directors/executives. Therefore, it is classified as a Director’s Dealing (insider trade) report.
2017-12-11 English
Indberetning af transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer udført af personer med nær tilknytning til personer med ledelsesansvar
Director's Dealing Classification · 100% confidence The document is a formal notification regarding transactions in ALK-Abelló A/S shares by a person closely associated with a member of the board of directors (Lene Skole). It explicitly references the Market Abuse Regulation (Markedsmisbrugsforordningen) Article 19, which governs the reporting of insider dealings. This fits the definition of a Director's Dealing (DIRS) report.
2017-12-11 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.